- Ajinomoto revised its full-year net income forecast to 74.90 billion yen.
- The company previously expected a net income of 95.00 billion yen.
- Market estimates had projected net income to be around 100.01 billion yen.
- Ajinomoto still expects net sales to be 1.53 trillion yen.
- Market estimates for net sales were slightly higher at 1.54 trillion yen.
- Analyst recommendations include 11 buy ratings, 6 hold ratings, and 1 sell rating.
A look at Ajinomoto Co Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 2 | |
| Dividend | 2 | |
| Growth | 3 | |
| Resilience | 3 | |
| Momentum | 3 | |
| OVERALL SMART SCORE | 2.6 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Analysts assessing Ajinomoto Co‘s long-term outlook through Smartkarma Smart Scores indicate a moderate stance overall. With scores of 2 for Value and Dividend, and slightly better scores of 3 for Growth, Resilience, and Momentum, the outlook suggests a mix of potential growth opportunities and stability within the company’s operations. Ajinomoto Co‘s diversified product portfolio, including food products, pharmaceuticals, amino acids, and specialty chemicals, provides a solid foundation for future growth.
Despite the average scores, Ajinomoto Co‘s focus on innovation and resilience, as reflected in its Smart Scores, may position the company well for long-term success. The relatively higher scores for Growth, Resilience, and Momentum hint at a company that is adapting to changing market conditions and poised for sustainable growth. Investors may find Ajinomoto Co an interesting prospect for a balanced investment strategy, considering its diverse product offerings and potential for future expansion.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
